Retrograde Nailing Versus Open Reduction and Internal Fixation for Unstable Fractures Around the Ankle in the Frail Elderly
Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Nov 10, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to treat unstable ankle fractures in elderly patients. Specifically, it compares a surgical procedure called open reduction and internal fixation (ORIF) with a technique known as retrograde intramedullary fibular nailing. The goal is to see which treatment leads to better recovery outcomes for patients one year after their injury. The trial is being conducted at multiple sites, with the London Health Sciences Centre as the lead location, and is currently recruiting participants.
To participate, you need to be at least 60 years old and have certain health conditions or types of ankle fractures that make you eligible. This includes having severe injuries or health issues like diabetes or frailty. If you join the trial, you'll be randomly assigned to one of the two treatment groups and will be asked to follow up after one year to see how well the treatment worked for you. It's important to note that not everyone can participate; for example, if you have a history of certain injuries or can't provide consent due to language barriers, you won't be eligible. This study aims to improve how ankle fractures are treated in older adults, helping them recover more effectively.
Gender
ALL
Eligibility criteria
- Patient Inclusion Criteria - Both Parts:
- (i) Age ≥ 60 years (ii) One or more of the following:
- • Severe soft tissue compromise
- • Significant co-morbidities (vascular disease + chronic trophic changes, diabetes + neuropathy, chronic renal failure, morbid obesity (BMI\> 40))
- • Frailty as defined by a Dalhousie Clinical Frailty Scale score ≥5 \[13\]
- Part 1 Specific Inclusion Criteria:
- • (i) Isolated fracture (within 4 weeks of injury): an AO/OTA type 43C2 or C3 tibial pilon fracture or severe ankle fracture (fracture-dislocation, severe joint impaction, severe trimalleolar)
- • Part 2 Specific Inclusion Criteria (i) Isolated fracture (within 4 weeks of injury): an AO/OTA type 44B2, B3, C1 or C2 ankle fracture
- Patient Exclusion Criteria - Both Parts:
- • (i) Presence of vascular injury or pathologic fracture; (ii) Previous tibia pilon fracture or retained hardware in affected limb; (iii) Refusal to participate; (iv) Inability to obtain informed consent due to language barrier
About London Health Sciences Centre Research Institute Or Lawson Research Institute Of St. Joseph's
The London Health Sciences Centre Research Institute, affiliated with Lawson Health Research Institute at St. Joseph's Health Care, is dedicated to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into practical applications, the institute fosters collaboration among leading researchers, clinicians, and healthcare professionals. It aims to improve patient outcomes and enhance the quality of care through rigorous investigation in areas such as cancer, cardiovascular health, and neuroscience. By integrating cutting-edge research with clinical practice, the institute plays a pivotal role in shaping the future of healthcare delivery in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials